Login Get Started
Browse
Shares
Healthcare
Healthcare Equipment & Supplies
VentriPoint Diagnostics
VentriPoint Diagnostics logo

VPT - VentriPoint Diagnostics News Story

C$0.17 0.0  3.0%

Last Trade - 22/01/21

Sector
Healthcare
RiskRating
Adventurous
Size
Micro Cap
Style
Momentum Trap
Market Cap £8.69m
Enterprise Value £9.08m
Revenue £21.5k
Position in Universe 1686th / 2682
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions VPT Dividends
All News

BRIEF-Ventripoint Receives Market Clearance From U.S. FDA For Complete Heart Analysis System Using 2D Ultrasound

VentriPoint Diagnostics News
Wed 16th May, 2018 1:43pm
May 16 (Reuters) - VentriPoint Diagnostics Ltd  VPT.V :
    * VENTRIPOINT RECEIVES MARKET CLEARANCE FROM US-FDA FOR
COMPLETE
HEART ANALYSIS SYSTEM USING 2D ULTRASOUND

Source text for Eikon:  ID:nGNX33Xwlm 
Further company coverage:  VPT.V 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on VentriPoint Diagnostics

See all news
BRIEF-Ventripoint Receives Market Clearance From U.S. FDA For Complete Heart Analysis System Using 2D Ultrasound
16th May '18 News
Ventripoint Receives Market Clearance from US-FDA for Complete Heart Analysis System Using 2D Ultrasound
16th May '18 News
BRIEF-Ventripoint Diagnostics says expecting marketing clearance for 4-chamber VMS in early 2018
20th Sep '17 News
BRIEF-Ventripoint announces increase in size of private placement
15th Mar '17 News
BRIEF-Ventripoint announces $2,000,000 non-brokered private placement
9th Mar '17 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.